You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Everolimus

Showing 51 - 75 of 1,264
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Tumors, Endocrine Breast Diseases, Tumor Metastasis Trial in Baltimore (letrozole, lapatinib, everolimus)

Terminated
Has Results
  • Breast Neoplasms
  • +2 more
  • Baltimore, Maryland
    University of Maryland Marlene & Stewart Greenebaum Cancer Cente
Feb 9, 2022

High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma Trial in Worldwide (Ribociclib, Everolimus)

Not yet recruiting
  • High Grade Glioma
  • +8 more
  • Aurora, Colorado
  • +17 more
May 2, 2023

Solid Organ Malignancies, Adenoidcystic Carcinoma, Neuroendocrine Tumors Trial in Atlanta (Lenalidomide, Everolimus)

Completed
Has Results
  • Solid Organ Malignancies
  • +2 more
  • Atlanta, Georgia
  • +1 more
Nov 19, 2021

Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Miami, Florida
    University of Miami
Apr 12, 2023

Neuroendocrine Tumors Trial in Boston, New York, Houston (LEE011, everolimus)

Active, not recruiting
  • Neuroendocrine Tumors
  • Boston, Massachusetts
  • +4 more
Feb 22, 2022

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer Trial in

Terminated
Has Results
  • Estrogen Receptor-positive Breast Cancer
  • +7 more
  • everolimus
  • +5 more
  • Atlanta, Georgia
  • +2 more
Mar 10, 2022

Coronary Artery Disease, Angina Pectoris, Myocardial Infarction Trial in Aarhus, Odense (Everolimus eluting bioresorbable

Active, not recruiting
  • Coronary Artery Disease
  • +2 more
  • Everolimus eluting bioresorbable polymer stent
  • Biolimus eluting bioresorbable polymer stent
  • Aarhus, Denmark
  • +1 more
Oct 17, 2022

Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +9 more
  • Everolimus
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

ER+, HER2-, Metastatic Breast Cancer Trial in China (AZD9833, AZD9833 with palbociclib, AZD9833 with everolimus)

Recruiting
  • ER+, HER2-, Metastatic Breast Cancer
  • Beijing, China
  • +5 more
Jan 13, 2023

Acute Coronary Syndrome Trial in Kyoto (No aspirin, 1-month DAPT)

Recruiting
  • Acute Coronary Syndrome
  • No aspirin
  • 1-month DAPT
  • Kyoto, Japan
    Kyoto University Graduate School of Medicine
Nov 16, 2022

Neuroendocrine Tumors, Lung Neuroendocrine Tumor, Thymus Tumors Trial in France, Italy, Spain (177Lu-edotreotide, Everolimus)

Not yet recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Bourdeaux, France
  • +24 more
Jun 23, 2023

Coronary Artery Disease Trial in Qingdao (Promus PREMIERTM Everolimus-Eluting Platinum Chromium Coronary Stent System)

Active, not recruiting
  • Coronary Artery Disease
  • Promus PREMIERTM Everolimus-Eluting Platinum Chromium Coronary Stent System
  • Qingdao, Shandong, China
    QiLu Hospital of ShanDong University
Jul 8, 2022

Renal Cell Carcinoma Trial in Shanghai (Anlotinib HCl, everolimus)

Not yet recruiting
  • Renal Cell Carcinoma
  • Anlotinib hydrochloride
  • everolimus
  • Shanghai, China
    270 Dongan Road, Fudan University Shanghai Cancer Center
Nov 5, 2021

Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 17, 2022

Cutaneous Squamous Cell Carcinoma, Advanced Cancer Trial in Boston (Cemiplimab, Everolimus, Sirolimus)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Advanced Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

Low Grade Glioma, World Health Organization (WHO) Grade II Astrocytomas, Oligodendrogliomas Trial in San Francisco (Everolimus,

Terminated
  • Low Grade Glioma
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Nov 3, 2021

XIENCE Skypoint Large Vessel Post Approval Study

Not yet recruiting
  • Coronary Artery Disease
  • XIENCE Skypoint Large Vessel Everolimus Eluting Coronary Stent System (EECSS)
  • (no location specified)
Jun 15, 2022

Primary Non-metastatic Breast Cancer, Who Remain Disease-free Trial in Lyon, Villejuif (Everolimus, Placebo)

Active, not recruiting
  • Primary Non-metastatic Breast Cancer
  • Who Remain Disease-free
  • Everolimus
  • Placebo
  • Lyon, France
  • +1 more
Feb 23, 2022

Differentiated Thyroid Cancer Trial in Philadelphia (Everolimus, Sorafenib)

Active, not recruiting
  • Differentiated Thyroid Cancer
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
Oct 18, 2021

Endometrial Cancer Trial in Pensacola, Voorhees, Houston (Metformin, Letrozole, Everolimus)

Active, not recruiting
  • Endometrial Cancer
  • Pensacola, Florida
  • +5 more
Feb 9, 2022

Renal Failure Trial in Columbus (Everolimus, Sirolimus)

Completed
Has Results
  • Renal Failure
  • Columbus, Ohio
    The Ohio State University Wexner Medical Center
Nov 2, 2021

Advanced Breast Cancer Trial in Lebanon (Fulvestrant, Neratinib, Alpelisib)

Not yet recruiting
  • Advanced Breast Cancer
  • Lebanon, New Hampshire
    Dartmouth Hitchcock Medical Center
Jun 28, 2023

Everolimus-containing Chemotherapy in HER2- mBC PI3K/AKT/mTOR

Completed
  • Breast Cancer
  • +2 more
  • No intervention, it was a retrospective study.
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Sep 13, 2021

Atherosclerosis Trial (Percutaneous coronary intervention PROMUS PREMIER)

Completed
Has Results
  • Atherosclerosis
  • Percutaneous coronary intervention PROMUS PREMIER
  • (no location specified)
Feb 23, 2022

Carcinoma, Renal Cell Trial in Worldwide (DFF332, RAD001, PDR001)

Recruiting
  • Carcinoma, Renal Cell
  • Duarte, California
  • +10 more
Jun 13, 2022